In a patient one week after knee replacement who now has shortness of breath, atrial fibrillation with rapid ventricular response, and a chest X‑ray showing a pleural effusion and increased bronchovascular markings, what is the appropriate initial work‑up and management?

Immediate Work-Up and Management for Post-Operative AFib with RVR and Pleural Effusion

This patient requires urgent evaluation for pulmonary embolism (PE) with CT pulmonary angiography (CTPA), immediate rate control with IV beta blockers (if hemodynamically stable), and assessment for anticoagulation once PE is ruled in or out.

Initial Diagnostic Approach

Rule Out Pulmonary Embolism First

• PE is the most critical diagnosis to exclude in this clinical scenario—a patient one week post-knee replacement (high VTE risk) presenting with new AFib with RVR, dyspnea, and pleural effusion 1
• Order CTPA immediately as the gold standard imaging modality 2
• Atrial fibrillation is strongly associated with PE-related pleural effusions (OR 1.89), and PE with effusion carries 30% increased mortality risk 1
• Do not delay imaging for troponin results—troponin testing is not universally required in AFib with RVR unless there are specific ACS risk factors 3

Characterize the Pleural Effusion

• The chest X-ray findings (fluidothorax with increased bronchovascular markings) suggest either:
  • Pulmonary embolism with infarction (most concerning given timing and AFib)
  • Acute pulmonary congestion from AFib with RVR causing acute heart failure
  • Post-surgical complication (though typically occurs earlier, mean 6.6 days post-op) 4

Immediate Management Algorithm

If Hemodynamically Unstable

• Urgent direct-current cardioversion is mandated per guidelines 5
• Hemodynamic compromise, ongoing ischemia, or inadequate rate control despite medications are Class I indications 5

If Hemodynamically Stable (Most Likely Scenario)

Step 1: Rate Control

• IV beta blockers are first-line for AFib with RVR in the absence of heart failure, hemodynamic instability, or bronchospasm 5
• Target heart rate <110 bpm initially
• Avoid beta blockers if signs of acute decompensated heart failure are present

Step 2: Anticoagulation Decision

• Calculate CHA₂DS₂-VASc score immediately
• If score ≥2: anticoagulation is Class I recommendation 5
• Critical caveat: Do NOT start anticoagulation until PE is ruled out or confirmed
  • If PE confirmed: therapeutic anticoagulation is both treatment and stroke prevention
  • If PE excluded and CHA₂DS₂-VASc ≥2: initiate anticoagulation for stroke prevention
• Post-operative timing (1 week) generally allows for anticoagulation if surgically appropriate

Step 3: Address Secondary Causes

• This is likely secondary AFib triggered by:
  • PE (most concerning)
  • Acute pulmonary congestion from rapid rate 6
  • Post-operative stress/inflammation
• Treating the underlying cause is paramount—AFib may resolve spontaneously once trigger is addressed

Risk Stratification for Acute Pulmonary Congestion

If PE is excluded, consider that acute pulmonary congestion (APC) occurs in 3.9% of AFib cardioversions and can present with the described X-ray findings 6. Risk factors present in this patient:

• Rapid ventricular response (OR 1.98) 6
• Post-operative state with potential volume shifts

Management if APC is diagnosed:

• IV diuretics
• Continue rate control
• Monitor oxygen saturation
• Serial chest X-rays to document improvement

Common Pitfalls to Avoid

1. Do not assume pleural effusion is simply from heart failure without excluding PE—this is a post-surgical orthopedic patient in the highest risk window for VTE
2. Do not start anticoagulation empirically before imaging if PE is suspected—you need the diagnosis confirmed
3. Do not perform routine thoracentesis if effusion is small-to-moderate and explained by CHF/PE 7—reserve for atypical features (fever, leukocytosis, marked asymmetry)
4. Do not use calcium channel blockers for rate control if there's any concern for heart failure—beta blockers are preferred 5

Disposition Considerations

• Admit for monitoring given:
  • New-onset AFib requiring rate control
  • Pending PE work-up
  • Post-operative status
  • Pleural effusion with respiratory symptoms
• APC following cardioversion (if performed) independently predicts increased 6-month readmissions (28.8% vs 18.1%) and mortality (HR 1.73) 6

Anticoagulation Specifics Once Initiated

• Direct oral anticoagulants (DOACs) are first-line over warfarin 3
• Ensure adequate renal function and no contraindications
• Post-operative bleeding risk must be weighed, but one week post-knee replacement typically allows for anticoagulation
• If PE is confirmed, standard PE treatment duration applies (minimum 3 months)